FDA NDC Directory · JSON-LD · Markdown

Reblozyl

NDC 59572-775 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameLuspatercept
Labeler / ManufacturerCelgene Corporation
Marketing categoryBiologic License Application · App BLA761136
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · SUBCUTANEOUS
Active ingredientsLUSPATERCEPT (75 mg/1)
Marketing started20191108
Package count1

External sources

Source: openFDA. Public-domain (CC0).